PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

40,991 stories, page 421 of 684

Advanced search
🌍discoverynews.google.comTier 3 · Aggregated media

FDA panel supports broadening access to peptides popular on the gray market

LAistOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA denies cooking oil sampling rumor

Taipei TimesOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Aspen positions itself as key African supplier of Merck HIV pill

Business DayOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

ICAR DG: Balanced Biotech Regulation for India''s Farm Sector

Rediff MoneyWizOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Enterprise value to revenue forward of Nascent Biotech Inc. – OTC:NBIO

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Orange juice residues contain hesperidin, limonene, valencene, and other substances that can become a source of valuable compounds for the pharmaceutical and cosmetic industries.

CPG Click Oil and GasOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Egypt to link drug prices to exchange rate and inflation

المنصة | ما رواه الناسOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Inside the record-breaking grocery nightmare Trump tried to hide from you

AlternetOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA panel backs 6 peptides in split, controversial vote

Rolling OutOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Missing ‘best-before’ dates at Pune sweet shops raise consumer concerns

The Indian ExpressOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Fugitive doctor on run for 21 years was living as L.A. biotech exec

AOL.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Tiansheng Pharmaceutical Group Co. Ltd. Class A Revenue Breakdown – SZSE:002872

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

LabTurbo Biotech Corporation Revenue Breakdown – TPEX:7725

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Arrowhead Pharmaceuticals (ARWR) Challenges Ionis (IONS) With Strong Phase 3 Data In Hypertriglyceridemia Race

londoninsider.co.ukOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

The Key to Thriving in Pharmaceutical Sciences

blackengineer.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Jyong Biotech Ltd (MENS) Risk Assessment: Volatility, Financial Risk & Investment Risk

TradingKeyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Charmacy Pharmaceutical Co., Ltd. Class H Revenue Breakdown – HKEX:2289

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

How Polpharma plans to build a CEE pharmaceutical platform

xyz.plOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA suspends Mumbai’s ‘Rustom’ ice cream parlour license over food safety breaches

The News MillOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

US tariff proposal wake-up call for Indian pharma to diversify, innovate: Experts

ET ManufacturingOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Innovative Drug Sector Strong Rally: Rebound or Full Reversal? Latest In-Depth Fund Manager Judgments

36 KrOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Sun Pharmaceutical Industries Limited Revenue Breakdown – NSE:SUNPHARMA

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Takeda Pharmaceutical (TSE:4502) Reports New Phase 3 Psoriasis Data, Is The 10% Discount Enough?

Yahoo Finance SingaporeOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

China Pharmaceutical Drying Equipment - Market Analysis, Forecast, Size, Trends and Insights

IndexBoxOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Teva Pharmaceutical Industries Limited (TEV) Q4 2025 Earnings Report - Results, Call & Slides

TipRanksOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Sartorius Stedim Biotech S.A. Just Missed EPS By 11%: Here's What Analysts Think Will Happen Next

simplywall.stOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

TKPH4770188 Bond Risk Profile

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Lawmakers debate GLP-1 regulation, expansion

AOL.caOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Judge rules FDA restrictions on mifepristone are arbitrary and capricious

AOL.caOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Arrowstreet Capital Limited Partnership Purchases 210,112 Shares of West Pharmaceutical Services, Inc. $WST

MarketBeatOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Consun Pharmaceutical Group Ltd. Revenue Breakdown – HKEX:1681

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Orforglipron News: Foundayo FDA Approved for Weight loss

GoodRxOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Cachet Pharmaceutical Co., Ltd. Class A Revenue Breakdown – SZSE:002462

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

West Pharmaceutical Services, Inc. $WST Shares Acquired by Bank of Nova Scotia

MarketBeatOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Whan In Pharmaceutical Co., Ltd. Revenue Breakdown – KRX:016580

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Enterprise value to EBIT forward of Zhuhai Rundu Pharmaceutical Co. Ltd. Class A – SZSE:002923

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

The LITMUS Study Just Changed How You Should Design Your MASLD Trial Endpoints

The Clinical Trial VanguardOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

TAK|Takeda Pharmaceutical Co Ltd|Price:17.240|Chg%:+0.435

TradingKeyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

West Pharmaceutical stock holds recent gains as investors weigh steady growth and guidance

AD HOC NEWSOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

WITHUS PHARMACEUTICAL Co., Ltd. Revenue Breakdown – KRX:330350

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Price to sales forward of Hunan Hansen Pharmaceutical Co., Ltd. Class A – SZSE:002412

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

West Pharmaceutical (WST) Signs Decade Long Daikyo Distribution Deal Beyond Japan

Yahoo Finance SingaporeOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Sex-Specific Safety Signals of Finerenone Versus Spironolactone: Insights From the FDA Adverse Event Reporting System

CureusOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Collegium Pharmaceutical, Inc. Revenue Breakdown – BOATS:COLL

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Enterprise value to EBITDA forward of Zhejiang Hisoar Pharmaceutical Co., Ltd. Class A – SZSE:002099

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Amgen Seeks FDA Hearing, Files New Data to Prevent Tavneos Market Withdrawal

Medical DialoguesOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Takeda (TSE:4502) Expands In Indonesia As Psoriasis Drug Delivers Phase 3 Data

Yahoo Finance UKOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

RARE|Ultragenyx Pharmaceutical Inc|Price:26.900|Chg%:-0.120

TradingKeyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Livzon Pharmaceutical Group Inc Class H Revenue Breakdown – LSX:A1XCAW

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

South Korea's Largest-Ever Pharmaceutical Industry M&A Deal: A Historic Milestone in the Making

36 KrOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Central Pharmaceutical CPC1.JSC Revenue Breakdown – UPCOM:DP1

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

VERAXA Biotech (NASDAQ: VRXA) Advances Lead BiTAC(R) T-Cell Engager Program with Cell Line Development Partnership

USA TodayOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

PRNAF SEC Filings - ALTERITY THERAPEUTICS LTD 10-K, 10-Q, 8-K Forms

Stock TitanOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

DWWD ETF Profile: Dividends, Returns (MUN:DWWD)

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

DXB: Phase 3 FSGS trial fully recruited; DMX-652 phase 2 ready; global deals up to AU$1.9B

TradingViewOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Mediators of treatment response in a clinical trial of naltrexone and bupropion for methamphetamine use disorder: A longitudinal mediation analysis.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Phase II Multicenter Clinical Trial of Intraoperative Molecular Imaging with Abenacianine During Lung Cancer Surgery.

Europe PMCOriginal source
🌍Researchdoi.orgTier 1 · Research record

Clinical Outcomes Following Definitive Concurrent Chemoradiotherapy in Patients With International Federation of Gynecology and Obstetrics (FIGO) Stage IB-IVA Carcinoma of the Cervix

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Orchestrating Modelling & Simulation of Pharmaceutical Production Processes Via Large Language Models

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Role of Multivariate Data Analyses In Formulation and Process Development of Oral Solid Drug Products: Encapsulation Case Studies

CrossrefOriginal source